Seeking Alpha
29 Jul 2026, 04:10 UTC · 3h ago
AnaptysBio: The Royalty Waterfall Is About To Reverse
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Seeking Alpha
29 Jul 2026, 04:10 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
4 claims · each scored for market impact
AnaptysBio has transitioned to a royalty management company with a targeted EBIT margin of 95%. — Extremely high margins and the elimination of R&D burn fundamentally re-rate the company's profitability profile.
+0.80The company holds over $140M in net cash. — Provides a significant liquidity cushion and potential for shareholder returns or strategic acquisitions.
+0.50The Sagard obligation is expected to be fully paid by mid-2027, after which ANAB will retain all high-margin royalty streams. — Creates a clear catalyst for increased free cash flow and valuation upside in the medium term.
+0.40Company value is now primarily tied to Jemperli royalties from GSK. — Concentrates risk on the commercial performance of a single drug asset.
Continue reading
6 related stories
Top 1 mover · tap to explore
Which stocks this story touches
Transition to a royalty management model eliminates R&D burn and establishes high targeted EBIT margins.
Mentioned as the source of royalties for Jemperli, but no direct positive or negative impact on GSK's operations is detailed.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Seeking Alpha
6h ago